Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Sep;25(3):459-69.

Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes

Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes

I C MacLennan et al. Immunology. 1973 Sep.

Abstract

It was possible to demonstrate complement fixation by IgG1 and IgG3 sub-class myeloma proteins which had been heat aggregated under standard conditions. Phagocytosis of bacteria by neutrophils was inhibited by IgG1, IgG2 and IgG3. Lysis of antibody-sensitized target cells by cytotoxic B lymphocytes was inhibited by all four sub-classes of IgG.

IgG interacted with cytotoxic B lymphocytes, neutrophils and complement only after physical alteration. Cytotoxic B cell reacting activity was acquired during protein purification procedures and was only slightly increased by heating. Neutrophil inhibition activity appeared only after the IgG sub-classes were heated and aggregation had occurred. Very large aggregates, however, were inefficient inhibitory units. Complement fixation by IgG1 and IgG3 was markedly increased by heating and the largest aggregates showed greatest activity.

PubMed Disclaimer

References

    1. J Immunol. 1965 Dec;95(6):1041-7 - PubMed
    1. J Immunol. 1967 Jul;99(1):82-91 - PubMed
    1. Nature. 1967 Dec 30;216(5122):1295-6 - PubMed
    1. Nature. 1969 Jan 11;221(5176):145-8 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed

LinkOut - more resources